|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM23684086X |
003 |
DE-627 |
005 |
20231224110414.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2014 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1002/adma.201305256
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0789.xml
|
035 |
|
|
|a (DE-627)NLM23684086X
|
035 |
|
|
|a (NLM)24677423
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Liu, Teng
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Drug delivery with PEGylated MoS2 nano-sheets for combined photothermal and chemotherapy of cancer
|
264 |
|
1 |
|c 2014
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 11.05.2015
|
500 |
|
|
|a Date Revised 21.03.2022
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
|
520 |
|
|
|a MoS2 nanosheets functionalized with poly-ethylene glycol are for the first time used as a multifunctional drug delivery system with high drug loading capacities. Using doxorubicin as the model drug and taking advantages of the strong near-infrared absorbance of MoS2, combined photothermal and chemotherapy of cancer is realized in animal experiments, achieving excellent synergistic anti-tumor effect upon systemic administration
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a 2D nanostructure
|
650 |
|
4 |
|a MoS2 nanosheet
|
650 |
|
4 |
|a combination therapy
|
650 |
|
4 |
|a drug delivery
|
650 |
|
4 |
|a photothermal therapy
|
650 |
|
7 |
|a Antineoplastic Agents
|2 NLM
|
650 |
|
7 |
|a Chlorophyllides
|2 NLM
|
650 |
|
7 |
|a Disulfides
|2 NLM
|
650 |
|
7 |
|a Drug Carriers
|2 NLM
|
650 |
|
7 |
|a Porphyrins
|2 NLM
|
650 |
|
7 |
|a Radiation-Sensitizing Agents
|2 NLM
|
650 |
|
7 |
|a Polyethylene Glycols
|2 NLM
|
650 |
|
7 |
|a 3WJQ0SDW1A
|2 NLM
|
650 |
|
7 |
|a phytochlorin
|2 NLM
|
650 |
|
7 |
|a 5S2CCF3T1Z
|2 NLM
|
650 |
|
7 |
|a Irinotecan
|2 NLM
|
650 |
|
7 |
|a 7673326042
|2 NLM
|
650 |
|
7 |
|a Doxorubicin
|2 NLM
|
650 |
|
7 |
|a 80168379AG
|2 NLM
|
650 |
|
7 |
|a Molybdenum
|2 NLM
|
650 |
|
7 |
|a 81AH48963U
|2 NLM
|
650 |
|
7 |
|a Camptothecin
|2 NLM
|
650 |
|
7 |
|a XT3Z54Z28A
|2 NLM
|
650 |
|
7 |
|a molybdenum disulfide
|2 NLM
|
650 |
|
7 |
|a ZC8B4P503V
|2 NLM
|
700 |
1 |
|
|a Wang, Chao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gu, Xing
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gong, Hua
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cheng, Liang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Shi, Xiaoze
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Feng, Liangzhu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sun, Baoquan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Liu, Zhuang
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 26(2014), 21 vom: 04. Juni, Seite 3433-40
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
773 |
1 |
8 |
|g volume:26
|g year:2014
|g number:21
|g day:04
|g month:06
|g pages:3433-40
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.201305256
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 26
|j 2014
|e 21
|b 04
|c 06
|h 3433-40
|